View by Specialty

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

Respiratory Infections News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 18, 2023
2 min read
Save

Hooked on ID with Priya Nori, MD, FSHEA, FIDSA

Hooked on ID with Priya Nori, MD, FSHEA, FIDSA

I became hooked on ID for the classic reasons — formative experiences in medical school and residency, a deep connection and kinship with supervising ID physicians during fellowship, immense learning opportunities, unforgettable mentor experiences, and tremendous personal and professional growth prospects.

SPONSORED CONTENT
July 18, 2023
11 min read
Save

Addressing physician burnout ‘a moral imperative’

Addressing physician burnout ‘a moral imperative’

Last year, U.S. Surgeon General Vivek Murthy, MD, issued an advisory on health worker burnout and well-being, declaring the situation a “crisis” and naming it a “top national priority.”

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

SPONSORED CONTENT
July 18, 2023
2 min read
Save

Reduced mechanical ventilation risk with corticosteroids in community-acquired pneumonia

Reduced mechanical ventilation risk with corticosteroids in community-acquired pneumonia

Fewer patients with community-acquired pneumonia using corticosteroids vs. standard care needed mechanical ventilation, but mortality rates did not differ between both groups, according to study results published in CHEST.

SPONSORED CONTENT
July 17, 2023
2 min read
Save

FDA approves monoclonal antibody to prevent RSV in infants

FDA approves monoclonal antibody to prevent RSV in infants

The FDA on Monday approved a monoclonal antibody for the prevention of respiratory syncytial virus lower respiratory tract disease in newborn and infants.

SPONSORED CONTENT
July 17, 2023
1 min read
Save

Infliximab effective as adjunctive therapy for patients with central nervous system TB

Infliximab effective as adjunctive therapy for patients with central nervous system TB

Infliximab was found to be safe and effective as adjunctive therapy for patients with central nervous system tuberculosis, researchers reported.

SPONSORED CONTENT
July 14, 2023
2 min read
Save

American Indian, Alaska Native children endure high rates of RSV

American Indian, Alaska Native children endure high rates of RSV

American Indian and Alaska Native children endure high rates of respiratory syncytial virus infection, a study published in Pediatrics found.

SPONSORED CONTENT
July 14, 2023
2 min read
Save

Among younger adults, Paxlovid shows benefits for some but not others

Among younger adults, Paxlovid shows benefits for some but not others

Paxlovid lowers the risk for severe COVID-19 among younger vaccinated adults with at least one serious comorbidity, researchers found, although their study did not see the same benefit for patients without medical comorbidities.

SPONSORED CONTENT
July 12, 2023
2 min read
Save

Deer may have transmitted SARS-CoV-2 back to humans, study finds

Deer may have transmitted SARS-CoV-2 back to humans, study finds

Thousands of samples taken from white-tailed deer in the U.S. showed that SARS-CoV-2 was transmitted from humans to deer more than 100 times, mutated, and then was potentially transmitted back to humans in three cases, researchers reported.

SPONSORED CONTENT
July 11, 2023
2 min read
Save

3-year wildfire smoke exposure raises all-cause, nonaccidental, neoplasm mortality risk

3-year wildfire smoke exposure raises all-cause, nonaccidental, neoplasm mortality risk

Risk for all-cause, nonaccidental and neoplasm mortality was heightened with exposure to elevated levels of wildfire-related fine particulate matter, according to study results published in the Journal of Hazardous Materials.

SPONSORED CONTENT
July 10, 2023
2 min read
Save

Early recognition could improve treatment of rare COVID-19-linked condition in adults

Early recognition could improve treatment of rare COVID-19-linked condition in adults

A study of more than 50 adults with a serious inflammatory syndrome linked to SARS-CoV-2 infection found that fewer than half were diagnosed with the condition while they were hospitalized.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails